Press release
Refractory Multiple Myeloma Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight | Sanofi, Karyopharm Therapeutics Inc, Regeneron Pharmaceuticals, Amgen, Oncotherapeutics, Takeda, Janssen Research & Development
Refractory Multiple Myeloma Market
Discover which therapies are expected to grab the Refractory Multiple Myeloma Market Share @ Refractory Multiple Myeloma Market Outlook- https://www.delveinsight.com/sample-request/refractory-multiple-myeloma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Refractory Multiple Myeloma Market Report
• In March 2025, Sanofi announced a study is to assess the efficacy (overall response rate) of subcutaneous (SC) via on body delivery system (SC-OBDS) isatuximab in combination with weekly carfilzomib and dexamethasone (Kd) in adult participants with RRMM having received 1 to 3 prior lines of therapy.
• In March 2025, Regeneron Pharmaceuticals announced a study is researching an experimental drug called REGN7945 in combination with another experimental drug called linvoseltamab, (also known as REGN5458) (each individually called a "study drug" or "study drugs" when combined).
• In March 2025, Kite, A Gilead Company announced a study (iMMagine-3) is to compare the study drug, anitocabtagene autoleucel to standard of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, including an anti-CD38 monoclonal antibody and an immunomodulatory drug.
• The increase in Refractory Multiple Myeloma Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Refractory Multiple Myeloma Market is anticipated to witness growth at a considerable CAGR.
• The leading Refractory Multiple Myeloma Companies such as Sanofi, Karyopharm Therapeutics Inc, Regeneron Pharmaceuticals, Amgen, Oncotherapeutics, Takeda, Janssen Research & Development LLC, AstraZeneca, Biocad, AbbVie, and others.
• Promising Refractory Multiple Myeloma Pipeline Therapies such as Isatuximab SC-OBDS, Montelukast, Dexamethasone, Elotuzumab, Iberdomide, Selinexor, Bortezomib and others.
Stay ahead in the Refractory Multiple Myeloma Therapeutics Market with DelveInsight's Strategic Report @ Refractory Multiple Myeloma Market Outlook- https://www.delveinsight.com/sample-request/refractory-multiple-myeloma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Refractory Multiple Myeloma Epidemiology Segmentation in the 7MM
The epidemiology section of Refractory Multiple Myeloma offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Refractory Multiple Myeloma Epidemiology trends @ Refractory Multiple Myeloma Prevalence- https://www.delveinsight.com/sample-request/refractory-multiple-myeloma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Refractory Multiple Myeloma Drugs Market
The Refractory Multiple Myeloma Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Refractory Multiple Myeloma signaling in Refractory Multiple Myeloma are likely to uncover new therapeutic targets and further expand treatment options for patients.
Refractory Multiple Myeloma Treatment Market Landscape
The Refractory Multiple Myeloma treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Refractory Multiple Myeloma has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Refractory Multiple Myeloma treatment guidelines, visit @ Refractory Multiple Myeloma Treatment Market Landscape- https://www.delveinsight.com/sample-request/refractory-multiple-myeloma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Refractory Multiple Myeloma Market Outlook
The report's outlook on the Refractory Multiple Myeloma market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Refractory Multiple Myeloma therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Refractory Multiple Myeloma drug and late-stage pipeline therapy.
Refractory Multiple Myeloma Drugs Uptake
The drug chapter of the Refractory Multiple Myeloma report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Refractory Multiple Myeloma.
Major Refractory Multiple Myeloma Companies
Sanofi, Karyopharm Therapeutics Inc, Regeneron Pharmaceuticals, Amgen, Oncotherapeutics, Takeda, Janssen Research & Development LLC, AstraZeneca, Biocad, AbbVie, and others.
Learn more about the FDA-approved drugs for Refractory Multiple Myeloma @ Drugs for Refractory Multiple Myeloma Treatment- https://www.delveinsight.com/sample-request/refractory-multiple-myeloma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Refractory Multiple Myeloma Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Refractory Multiple Myeloma Companies- Sanofi, Karyopharm Therapeutics Inc, Regeneron Pharmaceuticals, Amgen, Oncotherapeutics, Takeda, Janssen Research & Development LLC, AstraZeneca, Biocad, AbbVie, and others.
• Refractory Multiple Myeloma Pipeline Therapies- Isatuximab SC-OBDS, Montelukast, Dexamethasone, Elotuzumab, Iberdomide, Selinexor, Bortezomib and others.
• Refractory Multiple Myeloma Market Dynamics: Refractory Multiple Myeloma Market Drivers and Barriers
• Refractory Multiple Myeloma Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Refractory Multiple Myeloma Drugs in development @ Refractory Multiple Myeloma Clinical Trials Assessment- https://www.delveinsight.com/sample-request/refractory-multiple-myeloma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Refractory Multiple Myeloma Executive Summary
3. Competitive Intelligence Analysis for Refractory Multiple Myeloma
4. Refractory Multiple Myeloma: Market Overview at a Glance
5. Refractory Multiple Myeloma: Disease Background and Overview
6. Patient Journey
7. Refractory Multiple Myeloma Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Refractory Multiple Myeloma Unmet Needs
10. Key Endpoints of Refractory Multiple Myeloma Treatment
11. Refractory Multiple Myeloma Marketed Products
12. Refractory Multiple Myeloma Emerging Therapies
13. Refractory Multiple Myeloma: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Refractory Multiple Myeloma Market Outlook
16. Access and Reimbursement Overview of Refractory Multiple Myeloma
17. KOL Views
18. Refractory Multiple Myeloma Market Drivers
19. Refractory Multiple Myeloma Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
List of Top Selling Market Research Reports in 2025
Biopsy devices market- https://www.delveinsight.com/report-store/biopsy-devices-market
Diabetic wound market - https://www.delveinsight.com/report-store/diabetic-wounds-market
Joint reconstruction devices market- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Cystic fibrosis market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Heart failure market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
NK Cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Positive airway pressure device market - https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Thyroid cancer market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Uterine fibroids market- https://www.delveinsight.com/report-store/uterine-leiomyoma-uterine-fibroids-market
Attention deficit hyperactivity disorder adhd market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
Lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Refractory Multiple Myeloma Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight | Sanofi, Karyopharm Therapeutics Inc, Regeneron Pharmaceuticals, Amgen, Oncotherapeutics, Takeda, Janssen Research & Development here
News-ID: 3923549 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Refractory
Refractory Recycling Market May See a Big Move | Alfaref GmbH, Zarin Refractory, …
Advance Market Analytics published a new research publication on "Refractory Recycling Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Refractory Recycling market was mainly driven by the increasing R&D spending across the world.
Get inside Scoop of the report, request…
Checkpoint Inhibitor Refractory Cancer Market
Checkpoint Inhibitor Refractory Cancer Market Overview
The global Checkpoint Inhibitor Refractory Cancer Market is poised for significant growth, anticipating a high CAGR during the forecast period from 2023 to 2030.
Understanding Checkpoint Inhibitor Refractory Cancer
Refractory cancer, which might not respond to treatments immediately or might develop resistance later, has driven significant growth and transformation in the global checkpoint inhibitor refractory cancer market. The interest of oncologists in the potential antitumor activity of…
Refractory Chronic Cough Therapeutics Market - Silencing the Cough: Innovative T …
Newark, New Castle, USA: The "Refractory Chronic Cough Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Refractory Chronic Cough Therapeutics Market: https://www.growthplusreports.com/report/refractory-chronic-cough-therapeutics-market/7991
This latest report researches the…
Zirconium Corundum Brick Market Booming Worldwide( Forecast Period 2023-2029) Wi …
The global Zirconium Corundum Brick market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Zirconium Corundum Brick market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of…
Refractory Recycling Market is Booming Worldwide By Leading Players - SEBOREF s. …
This Refractory Recycling Market research report offers you an array of insights about Automotive industry and business solutions that will support to stay ahead of the competition. Systematic investment analysis is also underlined in this Refractory Recycling Market report which forecasts impending opportunities for the market players.This market report is the outcome of persistent efforts lead by knowledgeable forecasters, innovative analysts and brilliant researchers who carries out detailed and diligent…
Mullite Brick market 2018-19 Changxing Refractory,Zhengzhou Sunrise Refractory , …
Mullite Brick market Competitor Analysis:
Global Mullite Brick market 2019 by Future Market Reports presents a professional and complete analysis of on the current Industry situation. The Global report includes Mullite Brick Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Mullite Brick market players and the future prospects from various angles in detail. Industry…
